BISARO PAUL

Director at BARR PHARMACEUTICALS INC · on record since Jan 3, 2006
President & COO at BARR PHARMACEUTICALS INC · on record since Jan 3, 2006
former President & COO at BARR PHARMACEUTICALS INC · on record since Sep 27, 2007
Director at Allergan Finance LLC · on record since Sep 4, 2007
President & CEO at Allergan Finance LLC · on record since Sep 4, 2007
President and CEO at Impax Laboratories, LLC · on record since Mar 29, 2017
Director at ZIMMER BIOMET HOLDINGS, INC. · on record since Dec 16, 2013
Director at Zoetis Inc. · on record since May 13, 2026
Director at Allergan plc · on record since Mar 8, 2013
Director at MYRIAD GENETICS INC · on record since May 14, 2026
Director at Keenova Therapeutics plc · on record since Jun 4, 2026
Exec Chairman at Allergan plc · on record since Jul 3, 2014
Director at ALLERGAN INC · on record since Aug 24, 2015
Exec Chairman at ALLERGAN INC · on record since Aug 24, 2015
Director at Impax Laboratories, LLC · on record since Mar 29, 2017
Executive Chairman at Amneal Pharmaceuticals, Inc. · on record since Mar 12, 2019
Director at TherapeuticsMD, Inc. · on record since Mar 26, 2020
Director at Amneal Pharmaceuticals, Inc. · on record since May 8, 2018

Insider trading activity of BISARO PAUL

Transactions on record: 318; since Jul 31, 2003

Open-market buys: 7; $819.1K

Open-market sells: 49; $58.4M

Companies traded: 11; last filing Jul 17, 2026

Figures computed from official regulatory filings — .

Companies where BISARO PAUL has traded

24 tx · $47.1K · Jul 17, 2026
6 tx · $27.6K · Jun 5, 2026
35 tx · $891.7K · May 13, 2026
9 tx · $96.5K · Oct 3, 2022
9 tx · $371.9K · May 9, 2019
2 tx · May 8, 2018
22 tx · $25.4M · May 4, 2018
20 tx · Apr 4, 2017
21 tx · $103.3M · Mar 9, 2015
15 tx · $3.1M · Mar 16, 2012
155 tx · $55.4M · Oct 24, 2007

Track record of BISARO PAUL

Statistical track record

Free account

Open-market buys: 7

Last buy: May 14, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of BISARO PAUL

Co-insiders of BISARO PAUL

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Keenova Therapeutics plcListing unverified	Jul 17, 2026	AwardD (derivative)	4,406	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MYRIAD GENETICS INCListing on record	Jun 5, 2026	Award	59,701	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keenova Therapeutics plcListing unverified	Jun 4, 2026	Exercise	2,685	—	n/a (No price was disclosed in the filing)		SEC
Keenova Therapeutics plcListing unverified	Jun 4, 2026	OtherD (derivative)	-2,197	—	n/a (No price was disclosed in the filing)		SEC
Keenova Therapeutics plcListing unverified	Jun 4, 2026	ExerciseD (derivative)	-2,685	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keenova Therapeutics plcListing unverified	Jun 4, 2026	Other	-619	—	n/a (No price was disclosed in the filing)		SEC
MYRIAD GENETICS INCListing on record	May 14, 2026	Buy	7,500	3.69 USD	$27.6K	conv 45Cluster	SEC
Zoetis Inc.Listing on record	May 13, 2026	Buy	2,000	75.88 USD	$151.8K	conv 53ClusterFirst in 12mo	SEC
Keenova Therapeutics plcListing unverified	Feb 25, 2026	AwardD (derivative)	3,984	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zoetis Inc.Listing on record	Feb 23, 2026	ExerciseD (derivative)	-1,619.33	—	n/a (No price was disclosed in the filing)		SEC
Zoetis Inc.Listing on record	Feb 23, 2026	Exercise	1,619	—	n/a (No price was disclosed in the filing)		SEC
Zoetis Inc.Listing on record	Feb 19, 2026	AwardD (derivative)	1,936	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keenova Therapeutics plcListing unverified	Jan 5, 2026	OtherD (derivative)	-2,466	—	n/a (No price was disclosed in the filing)		SEC
Keenova Therapeutics plcListing unverified	Jan 5, 2026	ExerciseD (derivative)	-3,014	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keenova Therapeutics plcListing unverified	Jan 5, 2026	Exercise	3,014	—	n/a (No price was disclosed in the filing)		SEC
Keenova Therapeutics plcListing unverified	Jan 5, 2026	Other	-854	—	n/a (No price was disclosed in the filing)		SEC
Keenova Therapeutics plcListing unverified	Aug 18, 2025	AwardD (derivative)	4,062	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keenova Therapeutics plcListing unverified	Aug 4, 2025	AwardD (derivative)	27,357	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MYRIAD GENETICS INCListing on record	Jun 6, 2025	Award	49,796	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zoetis Inc.Listing on record	Feb 20, 2025	AwardD (derivative)	1,596	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zoetis Inc.Listing on record	Feb 11, 2025	Exercise	1,225	—	n/a (No price was disclosed in the filing)		SEC
Zoetis Inc.Listing on record	Feb 11, 2025	ExerciseD (derivative)	-1,225.4	—	n/a (No price was disclosed in the filing)		SEC
Zoetis Inc.Listing on record	Feb 10, 2025	ExerciseD (derivative)	-1,236.21	—	n/a (No price was disclosed in the filing)		SEC
Zoetis Inc.Listing on record	Feb 10, 2025	Exercise	1,236	—	n/a (No price was disclosed in the filing)		SEC
Keenova Therapeutics plcListing unverified	Jan 2, 2025	ExerciseD (derivative)	-2,507	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Keenova Therapeutics plcListing unverified	Jul 17, 2026	AwardD (derivative)	4,406	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MYRIAD GENETICS INCListing on record	Jun 5, 2026	Award	59,701	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keenova Therapeutics plcListing unverified	Jun 4, 2026	Exercise	2,685	—	n/a (No price was disclosed in the filing)		SEC
Keenova Therapeutics plcListing unverified	Jun 4, 2026	OtherD (derivative)	-2,197	—	n/a (No price was disclosed in the filing)		SEC
Keenova Therapeutics plcListing unverified	Jun 4, 2026	ExerciseD (derivative)	-2,685	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keenova Therapeutics plcListing unverified	Jun 4, 2026	Other	-619	—	n/a (No price was disclosed in the filing)		SEC
MYRIAD GENETICS INCListing on record	May 14, 2026	Buy	7,500	3.69 USD	$27.6K	conv 45Cluster	SEC
Zoetis Inc.Listing on record	May 13, 2026	Buy	2,000	75.88 USD	$151.8K	conv 53ClusterFirst in 12mo	SEC
Keenova Therapeutics plcListing unverified	Feb 25, 2026	AwardD (derivative)	3,984	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zoetis Inc.Listing on record	Feb 23, 2026	ExerciseD (derivative)	-1,619.33	—	n/a (No price was disclosed in the filing)		SEC
Zoetis Inc.Listing on record	Feb 23, 2026	Exercise	1,619	—	n/a (No price was disclosed in the filing)		SEC
Zoetis Inc.Listing on record	Feb 19, 2026	AwardD (derivative)	1,936	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keenova Therapeutics plcListing unverified	Jan 5, 2026	OtherD (derivative)	-2,466	—	n/a (No price was disclosed in the filing)		SEC
Keenova Therapeutics plcListing unverified	Jan 5, 2026	ExerciseD (derivative)	-3,014	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keenova Therapeutics plcListing unverified	Jan 5, 2026	Exercise	3,014	—	n/a (No price was disclosed in the filing)		SEC
Keenova Therapeutics plcListing unverified	Jan 5, 2026	Other	-854	—	n/a (No price was disclosed in the filing)		SEC
Keenova Therapeutics plcListing unverified	Aug 18, 2025	AwardD (derivative)	4,062	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keenova Therapeutics plcListing unverified	Aug 4, 2025	AwardD (derivative)	27,357	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MYRIAD GENETICS INCListing on record	Jun 6, 2025	Award	49,796	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zoetis Inc.Listing on record	Feb 20, 2025	AwardD (derivative)	1,596	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zoetis Inc.Listing on record	Feb 11, 2025	Exercise	1,225	—	n/a (No price was disclosed in the filing)		SEC
Zoetis Inc.Listing on record	Feb 11, 2025	ExerciseD (derivative)	-1,225.4	—	n/a (No price was disclosed in the filing)		SEC
Zoetis Inc.Listing on record	Feb 10, 2025	ExerciseD (derivative)	-1,236.21	—	n/a (No price was disclosed in the filing)		SEC
Zoetis Inc.Listing on record	Feb 10, 2025	Exercise	1,236	—	n/a (No price was disclosed in the filing)		SEC
Keenova Therapeutics plcListing unverified	Jan 2, 2025	ExerciseD (derivative)	-2,507	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC